Cardiovascular implantable electronic device-related infections linked with increased risk of death

September 12, 2011

An association has been found between infection associated with cardiovascular implantable electronic devices (CIEDs) and increases in mortality and hospital care costs, according to a report published Online First by Archives of Internal Medicine. The article is part of the journal's Health Care Reform series.

Therapy with CIEDs, which include , implantable cardioverter-defibrillators and /defibrillator devices, can reduce illness and in appropriately selected patients, according to background information in the article. However, complications including infection may mitigate this benefit. "Although it is well recognized that the rate of CIED infection is increasing faster than the rate of CIED implantation, there are limited published data on the risk-adjusted mortality and cost associated with CIED infection or the relationship of these outcomes to different CIED types," write the authors.

Muhammad R. Sohail, M.D., from the Mayo Clinic College of Medicine, Rochester, Minn., and colleagues analyzed the risk-adjusted total and incremental admission mortality, long-term mortality, admission length of stay (LOS) and admission cost associated with infection. They used data from the 100% Medicare Standard Analytic File Limited Data set version for inpatient admissions. The study group consisted of 200,219 Medicare fee-for-service patients who were admitted for CIED generator implantation, replacement or revision between January and December 2007. The researchers used the Centers for Medicare & Medicaid Services' payment-rate calculation methods, and used factors to reflect the admitting hospital's location, teaching status and indigent care load in order to standardize charges.

Researchers found a total of 5,817 admissions with infection. Depending on the CIED type, infection was associated with significant increases in adjusted admission mortality (4.6 percent to 11.3 percent, depending on type of device) and long-term mortality (26.5 percent to 35.1 percent, depending on type of device). Approximately half of the incremental long-term mortality occurred after patients were discharged. Depending on CIED type, the adjusted LOS was significantly longer with infection. With infection, the standardized adjusted incremental and total admission costs were $14,360 to $16,498 and $28,676 to $53,349, depending on CIED type. Intensive care accounted for more than 40 percent of the incremental admission cost. When researchers adjusted long-term mortality rate and cost ratios with infection by CIED type, pacemakers were associated with significantly greater increases in both measures, compared with implantable cardioverter-defibrillators or cardiac resynchronization therapy/defibrillator devices.

"Our work demonstrates that Medicare beneficiary admissions for CIED procedures with infection are associated with significant, device-dependent, incremental increases in admission mortality and long-term mortality, LOS, and cost compared with those without infection," write the authors. "Intensive care and pharmacy services accounted for more than half of the incremental cost with infection and could be targeted to reduce costs associated with management of CIED infection. The etiology of excess in patients with CIED infection after hospital discharge remains unclear and merits further investigation."

Explore further: Increase in infection rates in patients with cardiac electrophysiological devices

More information: Arch Intern Med. Published online September 12, 2011. doi:10.1001/archinternmed.2011.441

Related Stories

Increase in infection rates in patients with cardiac electrophysiological devices

August 22, 2011
New research from the Jefferson Heart Institute shows that patients in the United States who receive cardiac electrophysiological devices (CIEDs), including permanent pacemakers and implantable cardioverter-defibrillators ...

Study finds decrease in length of hospital stay after hip replacement, but increase in readmissions

April 19, 2011
An analysis of data from Medicare beneficiaries who underwent hip replacement or subsequent follow-up corrective surgery between 1991 and 2008 indicates that the length of hospital stay after surgery declined during this ...

Recommended for you

Two studies support intensive blood pressure control for long-term health, quality of life

August 23, 2017
Two studies provide additional support for lowering systolic blood pressure to an intensive goal of 120 mmHg - far below the standard guidelines of 140 mmHg - to reduce the risk of heart disease in high-risk patients with ...

Brain activity may be predictor of stress-related cardiovascular risk

August 23, 2017
The brain may have a distinctive activity pattern during stressful events that predicts bodily reactions, such as rises in blood pressure that increase risk for cardiovascular disease, according to new proof-of-concept research ...

Dramatic new studies into inflammation in the infarcted heart could lead to changes in therapy

August 23, 2017
A medical research collaborative has demonstrated that the response of the human heart to an infarction is very different than previously thought. The study, led by cardiologist Borja Ibáñez and published as two independent ...

'Shapeshifter' that regulates blood clotting is visually captured for the first time

August 23, 2017
We are normally born with a highly sophisticated array of molecules that act as "sentries," constantly scanning our bodies for injuries such as cuts and bruises. One such molecular sentry, known as von Willebrand factor (VWF), ...

New molecule may hold the key to triggering the regeneration and repair of damaged heart cells

August 21, 2017
New research has discovered a potential means to trigger damaged heart cells to self-heal. The discovery could lead to groundbreaking forms of treatment for heart diseases. For the first time, researchers have identified ...

Researchers investigate the potential of spider silk protein for engineering artificial heart

August 18, 2017
Ever more people are suffering from cardiac insufficiency, despite significant advances in preventing and minimising damage to the heart. The main cause of reduced cardiac functionality lies in the irreversible loss of cardiac ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.